tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market
Advertisement

MaaT Pharma (MAAT) Drug Pipeline

Compare
3 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Maat033
Amyotrophic Lateral Sclerosis, Als
Phase I
Completed
Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis
Apr 17, 2023
Pooled Allogeneic Fecal Microbiotherapy
Transplant Complication
Phase II
Recruiting
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
Jan 27, 2023
Maat013
Steroid Refractory Gvhd, Acute Graft Versus Host Disease In Intestine
Phase III
Active Not Recruiting
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
Feb 22, 2021
Maat033 Capsule
Hematologic Diseases, Chemotherapy Effect
Phase I
Completed
Safety and Tolerability Evaluation of MaaT033
Oct 25, 2019
Fecal Microbiota Transfer
Fecal Microbiota Transplantation
Phase II
Completed
Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer
Nov 20, 2017
Fecal Microbiota Transfer
Intensive Care Units, Fecal Microbiota Transplantation
Phase II
Terminated
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
Nov 14, 2017
Autologous Fecal Microbiota Transplantation
Leukemia, Myeloid, Acute
Phase I/II
Completed
PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients
May 26, 2016

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does MaaT Pharma (MAAT) have in its pipeline
      MAAT is currently developing the following drugs: Maat033, Pooled Allogeneic Fecal Microbiotherapy, Maat013. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis